Neonatal Adipocytokines and Longitudinal Patterns of Childhood Growth

Area of Science:

• Pediatric Endocrinology
• Metabolic Health
• Childhood Development

Background:

• Adipocytokines, like leptin and adiponectin, are key metabolic markers.
• The relationship between neonatal adipocytokines and long-term childhood growth patterns remains unclear.
• Understanding these associations is crucial for identifying early risk factors for childhood adiposity.

Purpose of the Study:

• To investigate the association between neonatal adipocytokine levels and longitudinal measures of childhood adiposity.
• To examine how early-life adipokine concentrations predict body mass index (BMI) z scores from infancy through early childhood.
• To differentiate the roles of leptin and adiponectin in childhood growth trajectories.

Main Methods:

• A prospective cohort study involving pregnant women and their children.
• Measurement of neonatal leptin and adiponectin concentrations at delivery.
• Assessment of children's BMI z scores from 4 weeks to 8 years of age, with analysis of BMI z score changes over time.

Main Results:

• Higher neonatal leptin levels were associated with greater BMI z scores in children, but this effect was nullified after adjusting for birth weight.
• Lower neonatal adiponectin levels were significantly associated with increased rates of BMI z score gain throughout the first 8 years of life.
• A significant interaction between adiponectin and age indicated differing growth trajectories based on initial adiponectin levels.

Conclusions:

• Lower concentrations of neonatal adiponectin are linked to accelerated BMI gains in early childhood.
• The association between neonatal leptin and childhood BMI may be confounded by birth weight, suggesting a complex interplay of factors.
• These findings highlight adiponectin as a potential early indicator of childhood adiposity risk.